NCT03628768View on ClinicalTrials.gov

Risk Factors for Falls and Neurocognitive Disorders CLSA

Active, not recruitingOBSERVATIONAL
Enrollment

12,000

Participants

Timeline

Start Date

July 23, 2019

Primary Completion Date

July 31, 2025

Study Completion Date

February 28, 2026

Conditions
Neurocognitive DisordersGeriatrics
Interventions
OTHER

Data collection

telephone interview questionnaire, in-home face-to-face interview, and data from the Collection Site

Trial Locations (1)

H3T 1E2

Jewish General Hospital, Montreal

All Listed Sponsors
lead

Jewish General Hospital

OTHER

NCT03628768 - Risk Factors for Falls and Neurocognitive Disorders CLSA | Biotech Hunter | Biotech Hunter